Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas

被引：0
|
作者：
Fardella, E. [1 ]
Zanirato, G. [2 ]
Magni, M. [2 ]
Caldarelli, N. [1 ]
Chiappella, A. [2 ]
Dodero, A. [2 ]
Ljevar, S. [3 ]
Orsucci, L. [4 ]
Re, A. [5 ]
Usai, S. V. [6 ]
Stefoni, V. [7 ]
Castellino, C. [8 ]
Rossi, F. G. [9 ]
Pinto, A. [10 ]
Carniti, C. [2 ]
Corradini, P. [1 ,2 ]
机构：
[1] Univ Milan, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Div Hematol & Stem Cell Transplantat, Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Unit Biostat Clin Res, Milan, Italy
[4] Azienda Osped & Univ Citta Salute & Sci, Div Hematol, Turin, Italy
[5] ASST Spedali Civili Brescia, Hematol Div, Brescia, Italy
[6] Osped Oncol Armando Businco, Hematol Unit, Cagliari, Italy
[7] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy
[8] Azienda Osped S Croce & Carle, Div Hematol, Cuneo, Italy
[9] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Div Hematol, Milan, Italy
[10] Fdn G Pascale, IRCCS Ist Nazl Tumori, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 204卷 / 05期
关键词：
DNA prognosis; haematological malignancies; prognostic factors; T-cell lymphoma; CANCER;
D O I：
10.1111/bjh.19280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell-free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre-treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression-free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre-treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.
引用
收藏
页码：1752 / 1756
页数：5
相关论文
共 50 条
  • [1] A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas
    Kim, Seok Jin
    Kang, Hye Jin
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Huh, Jooryung
    Ko, Young Hyeh
    Lee, Jongtae
    Yim, Dong-Seok
    Lee, Soo-Youn
    Park, Weon Seo
    Yang, Woo Ick
    Lee, Seung-Sook
    Suh, Cheolwon
    Kim, Won Seog
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1514 - 1521
  • [2] A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas
    Seok Jin Kim
    Hye Jin Kang
    Jin Seok Kim
    Hyeon-Seok Eom
    Jooryung Huh
    Young Hyeh Ko
    Jongtae Lee
    Dong-Seok Yim
    Soo-Youn Lee
    Weon Seo Park
    Woo Ick Yang
    Seung-Sook Lee
    Cheolwon Suh
    Won Seog Kim
    Investigational New Drugs, 2013, 31 : 1514 - 1521
  • [3] SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas
    Burton, Jackson S.
    Foley, Nicole C.
    Mehta-Shah, Neha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (02) : 65 - 76
  • [4] The predictive and prognostic significance of cell-free DNA concentration in melanoma
    Varaljai, R.
    Elouali, S.
    Lueong, S. S.
    Wistuba-Hamprecht, K.
    Seremet, T.
    Siveke, J. T.
    Becker, J. C.
    Sucker, A.
    Paschen, A.
    Horn, P. A.
    Neyns, B.
    Weide, B.
    Schadendorf, D.
    Roesch, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : 387 - 395
  • [5] The aggressive peripheral T-cell lymphomas: 2017
    Armitage, James O.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (07) : 706 - 715
  • [6] The aggressive peripheral T-cell lymphomas: 2015
    Armitage, James O.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 666 - 673
  • [7] Novel therapies for peripheral T-cell lymphomas
    Shustov, Andrei
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (03) : 173 - 187
  • [8] Treatment strategies for peripheral T-cell lymphomas
    Foss, Francine M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (01) : 43 - 56
  • [9] Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma
    Mizuno, Yuka
    Shibata, Sayaka
    Miyagaki, Tomomitsu
    Ito, Yukiko
    Taira, Haruka
    Omori, Issei
    Hisamoto, Teruyoshi
    Oka, Kenta
    Matsuda, Kazuki M.
    Boki, Hikari
    Takahashi-Shishido, Naomi
    Sugaya, Makoto
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2022, 49 (11) : 1124 - 1130
  • [10] BELINOSTAT FOR THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (05) : 337 - 345
12345